Time and Severe Hypoperfusion: 2 Threats for Hemorrhagic Transformation in Stroke
International Journal of Stroke (IJS) recently shared a post on X:
”Just Accepted!
Study finds hemorrhagic transformation was associated with onset-to-imaging time and presence of severe hypoperfusion. No interaction found between time and severe hypoperfusion.”
Read the full article here.
A new study is reinforcing the importance of timely management of stroke in an article ‘Association between Time and Severe Hypoperfusion with Risk of Hemorrhagic Transformation in Stroke Patients’ by Umberto Pensato et al., published in International Journal of Stroke (IJS).
Emerging evidence highlights that both severe hypoperfusion and time spent in a hypoperfused state contribute to the risk of parenchymal hematoma (PH) in ischemic stroke.
A recent analysis confirms that while each factor independently increases the likelihood of hemorrhagic transformation (HT), their interaction was not statistically significant.
These findings suggest that the risk of HT is influenced by distinct pathways related to hypoperfusion severity and duration.
Identifying patients with a “leaky core”—those with severely compromised blood-brain barriers—could enhance patient selection for targeted interventions!
Hemostasis Today, your daily update on scientific advancements in the World of Stroke.
-
Aug 31, 2025, 14:26Diego Segura-Rodríguez Shares ESC/EACTS Consensus on Post-CABG Antithrombotic Therapy
-
Aug 31, 2025, 09:45Slow Uptake of Hemophilia Gene Therapies: Challenges in Access and Adoption
-
Aug 30, 2025, 14:43Abdulla A. Damluji Questions Evidence for Beta-Blockers After MI Without Heart Failure
-
Aug 30, 2025, 14:42BDCC Future Leaders ’26: Empowering Teens Like Sarada Venigalla to Share Their Stories
-
Aug 30, 2025, 14:39Michael Makris Shares French Regulatory Update: Marstacimab (Hympavzi) Not Recommended for Severe Haemophilia A or B
-
Aug 31, 2025, 12:39Lupus Anticoagulant and Antiphospholipid Syndrome: Insights from Local Practice
-
Aug 31, 2025, 10:55NEJM Study: Aspirin with Oral Anticoagulation Raises Risks in Chronic Coronary Syndrome
-
Aug 31, 2025, 07:29Marcin Kurzyna: ESC Guidelines on Pregnancy and Cardiovascular Disease Highlight Updates in VTE Treatment
-
Aug 30, 2025, 14:44Sarah C. Hull: Evidence Supports Plant-Forward Diets, Not Raw Milk or Beef Tallow Trends
-
Aug 30, 2025, 14:43Extended Low-Dose Apixaban Reduces Risk of Recurrent VTE: HI-PRO Trial Results
-
Aug 29, 2025, 09:03Vasculearn Network: New 2025 High Blood Pressure Guidelines Are Here
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Aug 30, 2025, 14:45Gordon’s Journey: 60 Years of Life After DVT Managed with Warfarin
-
Aug 29, 2025, 19:10Mount Sinai’s Dr. Krittika Pant to Present Watchman Device Thrombosis Analysis at ESC Congress 2025
-
Aug 29, 2025, 09:02Flora Peyvandi: Join the Hemostasis Community at BIC 2025 in Italy
-
Aug 26, 2025, 09:42David McIntosh Highlights Global Blood Shortages and Fresh vs Stored RBCs
-
Aug 23, 2025, 07:48Protecting Heart and Brain Health: Stroke Prevention in Women with Bleeding Disorders: NBDF